Banque Pictet & Cie’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Banque Pictet & Cie’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-95,005	Closed	-$214K	–	342
2020 Q3	$214K	Buy	95,005 +24,625	+35%	+$70.3K	﹤0.01%	292
2020 Q2	$252K	Sell	70,380 -6,040	-8%	-$21.8K	﹤0.01%	297
2020 Q1	$290K	Sell	76,420 -451	-0.6%	-$1.49K	0.01%	291
2019 Q4	$231K	Buy	+76,871	New	+$200K	﹤0.01%	335

Other funds holding BMY.RT

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BFS

Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Banque Pictet & Cie's BMY.RT Position: Q4 2020 in Review

Banque Pictet & Cie sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q4 2020, closing a stake of 95,005 shares — an estimated $214K sold.

Banque Pictet & Cie first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $290K in Q1 2020. 546 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2020.

Banque Pictet & Cie reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q4 2020 after selling out during the quarter.
Banque Pictet & Cie sold 95,005 Bristol-Myers Squibb Company Contingent Value Rights shares in Q4 2020, an estimated $214K.
Banque Pictet & Cie first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
Banque Pictet & Cie's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $290K in Q1 2020.
546 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2020.

Based on Banque Pictet & Cie's 13F filing for Q4 2020, filed 10 Feb 2021.